IL2 and neoplasm: Whilst IL-2 and IL-15 overlap in several key functions, including supporting the proliferation and activation of NK cells, IL-2 can support the persistence of regulatory T cells (Tregs), which is an undesirable feature in the context of anti-tumour immunity [23,24].